Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Tauopathies are a class of neurodegenerative disorders characterized by abnormal deposition of post-translationally modified tau protein in the human brain. Tauopathies are associated with Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE), and other diseases. Hyperphosphorylation...
Main Authors: | Hamad Yadikar, Isabel Torres, Gabrielle Aiello, Milin Kurup, Zhihui Yang, Fan Lin, Firas Kobeissy, Richard Yost, Kevin K Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0224952 |
Similar Items
-
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
by: Natalia Shiryaev, et al.
Published: (2009-05-01) -
Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
by: Matthew R. Barron, et al.
Published: (2020-03-01) -
Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2015-01-01) -
Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy
by: Cowan, Catherine M., et al.
Published: (2010) -
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
by: Goran Šimić, et al.
Published: (2016-01-01)